H19 and cancer: Several lncRNAs, including Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1), H19 Imprinted Maternally Expressed Transcript (H19), and some others, have been shown to be candidate targets of promising therapeutic and diagnostic modalities for several cancers (28).